| GUBRA APS DK 1 |
| Dänemark |
| Gesundheit |
| DK0062266474 / A3D9NV |
| PI3 (Frankfurt) |
| FRA:PI3, ETR:PI3, PI3:GR |
| - |
| https://www.gubra.dk/ |
|
Gubra A/S is a biotechnology company specializing in preclinical contract research and peptide-based drug discovery, primarily targeting metabolic and fibrotic diseases. Headquartered in Hørsholm, Denmark, it focuses on the early stages of drug deve..
>Volltext.. |
| 835.3 Mio. EUR |
| 739.95 Mio. EUR |
| 35.36 Mio. EUR |
| -24 Mio. EUR |
| -23.78 Mio. EUR |
| -1.45 EUR |
| 24.35 Mio. EUR |
| 4.06 Mio. EUR |
| -99.07 Mio. EUR |
| 9.96 |
| -89.75% |
| -110.41% |
| - |
| - |
| - |
| 30.06.25 - 8.186725€ |
| - |
| GUBRA |
| 24.08.26 |
|
||||
|